Sei Investments Co. Buys 209,964 Shares of Bath & Body Works, Inc. $BBWI

Sei Investments Co. grew its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 62.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 547,297 shares of the company’s stock after purchasing an additional 209,964 shares during the period. Sei Investments Co.’s holdings in Bath & Body Works were worth $10,218,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Cetera Investment Advisers increased its position in Bath & Body Works by 19.5% during the 1st quarter. Cetera Investment Advisers now owns 56,001 shares of the company’s stock worth $1,046,000 after purchasing an additional 9,130 shares in the last quarter. First Trust Advisors LP boosted its position in Bath & Body Works by 19.7% in the first quarter. First Trust Advisors LP now owns 596,754 shares of the company’s stock valued at $11,141,000 after buying an additional 98,296 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in Bath & Body Works by 3.8% in the first quarter. PNC Financial Services Group Inc. now owns 61,225 shares of the company’s stock valued at $1,143,000 after buying an additional 2,248 shares in the last quarter. Parallel Advisors LLC grew its stake in shares of Bath & Body Works by 35.5% during the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock worth $48,000 after buying an additional 673 shares during the last quarter. Finally, KBC Group NV grew its stake in shares of Bath & Body Works by 27.7% during the first quarter. KBC Group NV now owns 6,903 shares of the company’s stock worth $129,000 after buying an additional 1,498 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have recently issued reports on BBWI shares. UBS Group lowered their price target on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, May 20th. Weiss Ratings raised Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 9th. TD Cowen boosted their price objective on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Piper Sandler assumed coverage on Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 target price for the company. Finally, The Goldman Sachs Group downgraded Bath & Body Works from a “neutral” rating to a “sell” rating and dropped their target price for the company from $23.00 to $19.00 in a research report on Wednesday, July 8th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $21.93.

Bath & Body Works Price Performance

BBWI opened at $20.13 on Friday. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $32.32. The firm has a market capitalization of $4.06 billion, a price-to-earnings ratio of 5.66, a PEG ratio of 1.99 and a beta of 1.38. The company’s 50 day moving average price is $20.15 and its two-hundred day moving average price is $20.37.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company’s revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities research analysts predict that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Investors of record on Friday, June 5th were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 4.0%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s dividend payout ratio is presently 22.47%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.